Pub Date : 2024-06-01DOI: 10.6705/j.jacme.202406_14(2).0003
Jack Healy, Ching-Fang Tiffany Tzeng, Jon Wolfshohl, Andrew Shedd, Judy Lin, Chinmay Patel, Eric H Chou
Background: Point-of-care ultrasound (POCUS) is a valuable tool that assists in diagnosis and management of patients in the emergency department (ED) while being cost-efficient and without the use of ionizing radiation. To discern the opinions and perceptions of ED staff about POCUS applications and barriers, we conducted a cross-sectional survey of employees of 12 EDs in North Texas.
Methods: Participants completed a 20-item online survey about POCUS with questions pertaining to four domains: (1) employee and training information, (2) perceived benefits, (3) common applications, and (4) barriers to use. Out of 805 eligible ED employees, 103 completed the survey (16.1% response rate).
Results: The results indicated a generally positive perception of POCUS among all employee types. Physician had significant exposure and training of POCUS than non-physician group ( p < 0.001). Physicians tend to find cardiac assessments more useful for clinical management than non-physicians (47% vs. 23%, p = 0.01), while non-physicians find soft tissue/abscess assessments more useful (27% vs. 9%, p = 0.01).
Conclusion: The most significant barriers to POCUS use were time constraints for physicians and a lack of training for non-physician employees. Our study provides valuable insights into the perceptions of multiple ED professionals, serving as a foundation for promoting POCUS use in the ED.
{"title":"Point-of-Care Ultrasound in the Emergency Department: Training, Perceptions, Applications, and Barriers from Different Healthcare Professionals.","authors":"Jack Healy, Ching-Fang Tiffany Tzeng, Jon Wolfshohl, Andrew Shedd, Judy Lin, Chinmay Patel, Eric H Chou","doi":"10.6705/j.jacme.202406_14(2).0003","DOIUrl":"10.6705/j.jacme.202406_14(2).0003","url":null,"abstract":"<p><strong>Background: </strong>Point-of-care ultrasound (POCUS) is a valuable tool that assists in diagnosis and management of patients in the emergency department (ED) while being cost-efficient and without the use of ionizing radiation. To discern the opinions and perceptions of ED staff about POCUS applications and barriers, we conducted a cross-sectional survey of employees of 12 EDs in North Texas.</p><p><strong>Methods: </strong>Participants completed a 20-item online survey about POCUS with questions pertaining to four domains: (1) employee and training information, (2) perceived benefits, (3) common applications, and (4) barriers to use. Out of 805 eligible ED employees, 103 completed the survey (16.1% response rate).</p><p><strong>Results: </strong>The results indicated a generally positive perception of POCUS among all employee types. Physician had significant exposure and training of POCUS than non-physician group ( <i>p</i> < 0.001). Physicians tend to find cardiac assessments more useful for clinical management than non-physicians (47% vs. 23%, <i>p</i> = 0.01), while non-physicians find soft tissue/abscess assessments more useful (27% vs. 9%, <i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>The most significant barriers to POCUS use were time constraints for physicians and a lack of training for non-physician employees. Our study provides valuable insights into the perceptions of multiple ED professionals, serving as a foundation for promoting POCUS use in the ED.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 2","pages":"74-89"},"PeriodicalIF":0.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-01DOI: 10.6705/j.jacme.202406_14(2).0002
Eric Lam, Sandra Gomez-Paz, Luis Fernando Gonzalez-Mosquera, Steven Mirabella, Diana Cardenas-Maldonado, Joshua Fogel, Sofia Rubinstein
Background: Coronavirus disease 2019 (COVID-19) has multiple organ system involvement but the association of organ system involvement with disease prognosis has not been reported. We study the association of organ systems involved with in-hospital mortality and hospital length of stay (LOS) in COVID-19.
Methods: Retrospective study of 808 consecutive patients with confirmed-laboratory diagnosis of COVID-19 in a New York hospital from March 1-May 15, 2020.
Results: Increased number of organs systems involved was associated with increased odds for in-hospital mortality (odds ratio [OR]: 1.36, 95% confidence interval [CI]: 1.11-1.66, p < 0.01) and increased LOS (B = 0.02, SE = 0.01, p < 0.05). Increased platelet count was associated with decreased odds for mortality (OR: 0.996, 95% CI: 0.994-0.998, p < 0.001). Increased white blood cell count was associated with increased odds for mortality (OR: 14.00, 95% CI: 3.41-57.38, p < 0.001). Increased creatinine and glucose were each associated with increased LOS (B = 0.11, SE = 0.04, p < 0.01, and B = 0.12, SE = 0.05, p < 0.05, respectively). Increased odds for mortality were also found in high FiO2 oxygen requirement (OR: 11.63, 95% CI: 3.90-34.75, p < 0.001) and invasive mechanical ventilation (OR: 109.93, 95% CI: 29.44-410.45, p < 0.001).
Conclusion: Multiple organ systems involvement in COVID-19 is associated with worse prognosis. Clinical/laboratory values corresponding to each organ system may be used as prognostic tools in clinical settings to tailor treatments for COVID-19 patients.
{"title":"Multi-Organ Systems Involvement in COVID-19 is Associated With a Worse Prognosis.","authors":"Eric Lam, Sandra Gomez-Paz, Luis Fernando Gonzalez-Mosquera, Steven Mirabella, Diana Cardenas-Maldonado, Joshua Fogel, Sofia Rubinstein","doi":"10.6705/j.jacme.202406_14(2).0002","DOIUrl":"10.6705/j.jacme.202406_14(2).0002","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) has multiple organ system involvement but the association of organ system involvement with disease prognosis has not been reported. We study the association of organ systems involved with in-hospital mortality and hospital length of stay (LOS) in COVID-19.</p><p><strong>Methods: </strong>Retrospective study of 808 consecutive patients with confirmed-laboratory diagnosis of COVID-19 in a New York hospital from March 1-May 15, 2020.</p><p><strong>Results: </strong>Increased number of organs systems involved was associated with increased odds for in-hospital mortality (odds ratio [OR]: 1.36, 95% confidence interval [CI]: 1.11-1.66, <i>p</i> < 0.01) and increased LOS (B = 0.02, SE = 0.01, <i>p</i> < 0.05). Increased platelet count was associated with decreased odds for mortality (OR: 0.996, 95% CI: 0.994-0.998, <i>p</i> < 0.001). Increased white blood cell count was associated with increased odds for mortality (OR: 14.00, 95% CI: 3.41-57.38, <i>p</i> < 0.001). Increased creatinine and glucose were each associated with increased LOS (B = 0.11, SE = 0.04, <i>p</i> < 0.01, and B = 0.12, SE = 0.05, <i>p</i> < 0.05, respectively). Increased odds for mortality were also found in high FiO2 oxygen requirement (OR: 11.63, 95% CI: 3.90-34.75, <i>p</i> < 0.001) and invasive mechanical ventilation (OR: 109.93, 95% CI: 29.44-410.45, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Multiple organ systems involvement in COVID-19 is associated with worse prognosis. Clinical/laboratory values corresponding to each organ system may be used as prognostic tools in clinical settings to tailor treatments for COVID-19 patients.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 2","pages":"61-73"},"PeriodicalIF":0.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11153311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141296099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.6705/j.jacme.202403_14(1).0005
Chang-Han Wu, Chi-Wei Chen, Liang-Chi Kuo
Ocular globe injury is a severe ophthalmic emergency that requires immediate attention in the emergency department. In this case report, we present a 35-year-old male who suffered a penetrating ocular injury and globe rupture caused by a nail puncture. The patient presented with severe pain and visual loss and was treated with tetanus vaccination, empirical antibiotics, and pain control, followed by an urgent orbital computed tomography (CT) scan and consultation with an ophthalmologist. The CT scan revealed a retained nail in the ocular space, and an urgent operation was performed to repair the eyeball rupture, remove the intraocular foreign body, and perform an anterior vitrectomy. The patient was discharged 6 days after the operation with a visual acuity of 20/400 and an ocular trauma score of 34. This case highlights the importance of initial emergency physician decision-making and the need for a thorough history-taking and examination when encountering penetrating ocular injuries.
{"title":"Urgent Management of Penetrating Ocular Injury: A Case Report and Review of the Literature.","authors":"Chang-Han Wu, Chi-Wei Chen, Liang-Chi Kuo","doi":"10.6705/j.jacme.202403_14(1).0005","DOIUrl":"10.6705/j.jacme.202403_14(1).0005","url":null,"abstract":"<p><p>Ocular globe injury is a severe ophthalmic emergency that requires immediate attention in the emergency department. In this case report, we present a 35-year-old male who suffered a penetrating ocular injury and globe rupture caused by a nail puncture. The patient presented with severe pain and visual loss and was treated with tetanus vaccination, empirical antibiotics, and pain control, followed by an urgent orbital computed tomography (CT) scan and consultation with an ophthalmologist. The CT scan revealed a retained nail in the ocular space, and an urgent operation was performed to repair the eyeball rupture, remove the intraocular foreign body, and perform an anterior vitrectomy. The patient was discharged 6 days after the operation with a visual acuity of 20/400 and an ocular trauma score of 34. This case highlights the importance of initial emergency physician decision-making and the need for a thorough history-taking and examination when encountering penetrating ocular injuries.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"39-41"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.6705/j.jacme.202403_14(1).0006
Ewe Jin Koh, Xiao Qi Yee, Ming Lee Chin, Nisa Liyana Bt Abdul Latib
A 53-year-old presented to the emergency department following a fall and was found to have recurrent episodes of torsades de pointes and pulseless ventricular tachycardia on cardiac monitoring. He had been abusing nimetazepam for sleep issues over the preceding one month. Despite correction of electrolytes, the arrhythmias were persistent which necessitated temporary overdrive pacing. The patient made an uneventful recovery and the temporary pacing was successfully removed with no recurrence of the malignant arrhythmias prior to discharge.
{"title":"Overdrive Pacing for Persistent Torsades de Pointes and Pulseless Ventricular Tachycardia.","authors":"Ewe Jin Koh, Xiao Qi Yee, Ming Lee Chin, Nisa Liyana Bt Abdul Latib","doi":"10.6705/j.jacme.202403_14(1).0006","DOIUrl":"10.6705/j.jacme.202403_14(1).0006","url":null,"abstract":"<p><p>A 53-year-old presented to the emergency department following a fall and was found to have recurrent episodes of torsades de pointes and pulseless ventricular tachycardia on cardiac monitoring. He had been abusing nimetazepam for sleep issues over the preceding one month. Despite correction of electrolytes, the arrhythmias were persistent which necessitated temporary overdrive pacing. The patient made an uneventful recovery and the temporary pacing was successfully removed with no recurrence of the malignant arrhythmias prior to discharge.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"42-47"},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Low-flow extracorporeal CO 2 removal (ECCO 2 R), managed using a renal replacement platform, is useful in achieving lung-protective ventilation with low tidal volume. However, its capacity for CO 2 elimination is limited. Whether this system is valuable in reducing strong inspiratory efforts in respiratory failure is unclear. The combined use of alkaline agents with low-flow ECCO 2 R might be useful in hypercapnic subjects preserving inspiratory efforts.
Methods: This study examined the effects of low-flow ECCO 2 R on respiratory status and investigated the effects of NaHCO 3 , trometamol, and saline on respiratory status during low-flow ECCO 2 R in CO 2 inhalation models.
Results: Although low-flow ECCO 2 R did not significantly change the respiratory rate (92.2% ± 24.3% [mean ± standard deviation] of that before ECCO 2 R), it reduced minute ventilation (MV) (78.9% ± 13.5% of that before ECCO 2 R). The addition of NaHCO 3 improved acidemia but did not change MV compared with that of the saline group (0.451 ± 0.026 L/min/kg body weight [BW] vs. 0.556 ± 0.138 L/min/kg BW, respectively). The addition of trometamol improved acidemia and reduced MV compared with that of the saline group (0.381 ± 0.050 L/min/kg BW vs. 0.556 ± 0.138 L/min/kg BW, respectively). The total amounts of CO 2 removed during ECCO 2 R in the NaHCO 3 group were lower than those in the saline and trometamol groups.
Conclusion: The low-flow ECCO 2 R reduced MV in subjects preserving spontaneous breathing efforts with CO 2 overload. The addition of NaHCO 3 improved acidemia but did not change MV, whereas the addition of trometamol improved acidemia and reduced MV.
背景:使用肾脏替代平台管理的低流量体外二氧化碳排出器(ECCO 2 R)有助于以低潮气量实现肺保护性通气。然而,它排除二氧化碳的能力有限。目前还不清楚该系统在减少呼吸衰竭患者强烈吸气方面是否有价值。将碱性制剂与低流量 ECCO 2 R 结合使用可能对高碳酸血症患者的吸气努力有所帮助:本研究探讨了低流量 ECCO 2 R 对呼吸状态的影响,并研究了 NaHCO 3、曲美他莫和生理盐水对二氧化碳吸入模型中低流量 ECCO 2 R 期间呼吸状态的影响:结果:虽然低流量 ECCO 2 R 没有显著改变呼吸频率(ECCO 2 R 前的 92.2% ± 24.3% [平均值 ± 标准差]),但降低了分钟通气量(MV)(ECCO 2 R 前的 78.9% ± 13.5%)。与生理盐水组相比,添加 NaHCO 3 可改善酸血症,但不会改变通气量(分别为 0.451 ± 0.026 升/分钟/千克体重[BW] 与 0.556 ± 0.138 升/分钟/千克体重[BW])。与生理盐水组相比,添加曲美他莫可改善酸血症并降低血压(分别为 0.381 ± 0.050 升/分钟/千克体重 vs 0.556 ± 0.138 升/分钟/千克体重)。NaHCO 3 组在 ECCO 2 R 期间排出的 CO 2 总量低于生理盐水组和曲美他莫组:结论:低流量 ECCO 2 R 降低了受试者在 CO 2 超负荷时保持自主呼吸的 MV。添加 NaHCO 3 可改善酸血症,但不会改变 MV,而添加曲美他莫可改善酸血症并降低 MV。
{"title":"Combined Use of Alkaline Agents With Low-Flow Extracorporeal Carbon Dioxide Removal in Carbon Dioxide Inhalation Models Preserving Inspiratory Efforts.","authors":"Tomonori Yamashita, Akinori Uchiyama, Yusuke Enokidani, Takeshi Yoshida, Yuji Fujino","doi":"10.6705/j.jacme.202403_14(1).0004","DOIUrl":"10.6705/j.jacme.202403_14(1).0004","url":null,"abstract":"<p><strong>Background: </strong>Low-flow extracorporeal CO <sub>2</sub> removal (ECCO <sub>2</sub> R), managed using a renal replacement platform, is useful in achieving lung-protective ventilation with low tidal volume. However, its capacity for CO <sub>2</sub> elimination is limited. Whether this system is valuable in reducing strong inspiratory efforts in respiratory failure is unclear. The combined use of alkaline agents with low-flow ECCO <sub>2</sub> R might be useful in hypercapnic subjects preserving inspiratory efforts.</p><p><strong>Methods: </strong>This study examined the effects of low-flow ECCO <sub>2</sub> R on respiratory status and investigated the effects of NaHCO <sub>3</sub> , trometamol, and saline on respiratory status during low-flow ECCO <sub>2</sub> R in CO <sub>2</sub> inhalation models.</p><p><strong>Results: </strong>Although low-flow ECCO <sub>2</sub> R did not significantly change the respiratory rate (92.2% ± 24.3% [mean ± standard deviation] of that before ECCO <sub>2</sub> R), it reduced minute ventilation (MV) (78.9% ± 13.5% of that before ECCO <sub>2</sub> R). The addition of NaHCO <sub>3</sub> improved acidemia but did not change MV compared with that of the saline group (0.451 ± 0.026 L/min/kg body weight [BW] vs. 0.556 ± 0.138 L/min/kg BW, respectively). The addition of trometamol improved acidemia and reduced MV compared with that of the saline group (0.381 ± 0.050 L/min/kg BW vs. 0.556 ± 0.138 L/min/kg BW, respectively). The total amounts of CO <sub>2</sub> removed during ECCO <sub>2</sub> R in the NaHCO <sub>3</sub> group were lower than those in the saline and trometamol groups.</p><p><strong>Conclusion: </strong>The low-flow ECCO <sub>2</sub> R reduced MV in subjects preserving spontaneous breathing efforts with CO <sub>2</sub> overload. The addition of NaHCO <sub>3</sub> improved acidemia but did not change MV, whereas the addition of trometamol improved acidemia and reduced MV.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"28-38"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.6705/j.jacme.202403_14(1).0003
Kadir Küçükceran, Mustafa Kürşat Ayrancı, Abdullah Sadık Girişgin, Sedat Koçak, Zerrin Defne Dündar, Osman Koç
Background: It is important to investigate the factors that may delay the diagnosis and treatment process of ischemic stroke. The aim of this study was to investigate whether in-hospital mortality increased in patients who presented to the emergency department out-of-hours and underwent thrombectomy.
Methods: A total of 59 patients who applied to the emergency department between January 1, 2018 and November 1, 2021 and underwent thrombectomy due to ischemic stroke were included in the study. Patient age, gender, thrombectomy success (successful recanalization), in-hospital mortality status, intracranial hemorrhage status after thrombectomy, and out-of-hours admission status were recorded and compared according to out-of-hours admission status.
Results: Twenty-seven (45.8%) patients were male, and the median age was 74 (61-81) years. Forty-two (71.2%) patients applied to the emergency department out-of-hours. In-hospital mortality occurred in 27 (45.8%) patients. There was no statistically significant difference in out-of-hours admission status between the non-survivor group and the survivor group (non-survivor: 24 [75%]; survivor: 18 [66.7%], p = 0.481). Nor was a statistically significant difference found in the intracranial hemorrhage complication rate of the patients admitted out-of-hours compared to the patients admitted during working hours (out-of-hours: 17 [40.5%]; during working hours: 6 [35.3%], p = 0.712).
Conclusion: No statistically significant difference was found in the rate of in-hospital mortality and intracranial bleeding complications in patients who underwent thrombectomy out of working hours compared to during working hours.
{"title":"The Effect of Out-of-Hours Admission on Mortality in Patients Who Underwent Thrombectomy Due to Ischemic Stroke.","authors":"Kadir Küçükceran, Mustafa Kürşat Ayrancı, Abdullah Sadık Girişgin, Sedat Koçak, Zerrin Defne Dündar, Osman Koç","doi":"10.6705/j.jacme.202403_14(1).0003","DOIUrl":"10.6705/j.jacme.202403_14(1).0003","url":null,"abstract":"<p><strong>Background: </strong>It is important to investigate the factors that may delay the diagnosis and treatment process of ischemic stroke. The aim of this study was to investigate whether in-hospital mortality increased in patients who presented to the emergency department out-of-hours and underwent thrombectomy.</p><p><strong>Methods: </strong>A total of 59 patients who applied to the emergency department between January 1, 2018 and November 1, 2021 and underwent thrombectomy due to ischemic stroke were included in the study. Patient age, gender, thrombectomy success (successful recanalization), in-hospital mortality status, intracranial hemorrhage status after thrombectomy, and out-of-hours admission status were recorded and compared according to out-of-hours admission status.</p><p><strong>Results: </strong>Twenty-seven (45.8%) patients were male, and the median age was 74 (61-81) years. Forty-two (71.2%) patients applied to the emergency department out-of-hours. In-hospital mortality occurred in 27 (45.8%) patients. There was no statistically significant difference in out-of-hours admission status between the non-survivor group and the survivor group (non-survivor: 24 [75%]; survivor: 18 [66.7%], <i>p</i> = 0.481). Nor was a statistically significant difference found in the intracranial hemorrhage complication rate of the patients admitted out-of-hours compared to the patients admitted during working hours (out-of-hours: 17 [40.5%]; during working hours: 6 [35.3%], <i>p</i> = 0.712).</p><p><strong>Conclusion: </strong>No statistically significant difference was found in the rate of in-hospital mortality and intracranial bleeding complications in patients who underwent thrombectomy out of working hours compared to during working hours.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"20-27"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.6705/j.jacme.202403_14(1).0001
Vedran Kovacic
Sepsis is a potentially fatal organ failure produced by the host's immune response to infection. It is critical to identify risk factors associated with a poor prognosis in septic patients in order to develop new therapy options. Vitamin D deficiency (25-hydroxyvitamin cholecalciferol < 20 ng/mL) is common in critical and septic patients. Serum vitamin D concentrations are associated with an increased incidence of mortality in critically ill adult patients. In critically ill patients, vitamin D supplementation (a very high vitamin D 3 or cholecalciferol loading dosage as a single bolus dose ranging from 400,000 to 540,000 IU) is feasible and safe. Some of the trials and their post-hoc analyses evaluating vitamin D supplementation in severely sick individuals, including septic patients, suggested possible benefits in mortality (reduced 28-day mortality in the range of 8.1%-17.5%), and other outcomes (reduction in hospital length in the range from 9 to 18 days, and decrease in duration of mechanical ventilation in the range from 5 to 10 days). Despite the fact that many studies support the provision of vitamin D to septic patients, there are still many studies that contradict this opinion, and there is still debate about the recommendation to use vitamin D in sepsis. A pragmatic clinical approach in severe sepsis could be supplementation of vitamin D if serum levels are diminished (< 30 ng/mL). It appears that a single ultrahigh dose of vitamin D 3 (cholecalciferol) could be administered to the septic patient via an enteral tube, followed by daily or monthly maintenance doses. Parenteral administration might be reserved for a subgroup of septic patients with gastrointestinal, hepatic, or renal dysfunction. Future clinical trials designed exclusively for septic patients are required to assess the potential advantages of vitamin D. Possible impacts of selective activators of vitamin D receptors, such as paricalcitol, should be elucidated in sepsis. This emphasizes the requirement for more study and confirmation of any potential beneficial effects of vitamin D in sepsis.
败血症是宿主对感染的免疫反应导致的潜在致命性器官衰竭。确定与败血症患者预后不良相关的风险因素以开发新的治疗方案至关重要。维生素 D 缺乏(25-羟维生素胆钙化醇 < 20 ng/mL)在危重病人和脓毒症患者中很常见。血清维生素 D 浓度与成年重症患者死亡率的增加有关。在危重病人中,补充维生素 D(维生素 D 3 或胆钙化醇的负荷剂量非常高,单次栓剂剂量从 400,000 到 540,000 IU 不等)是可行且安全的。一些对重症患者(包括败血症患者)补充维生素 D 进行评估的试验及其事后分析表明,补充维生素 D 可降低死亡率(28 天死亡率降低了 8.1%-17.5%)和其他结果(住院时间缩短了 9 到 18 天,机械通气时间缩短了 5 到 10 天)。尽管许多研究都支持为脓毒症患者提供维生素 D,但仍有许多研究与这一观点相悖,关于在脓毒症患者中使用维生素 D 的建议仍存在争议。在严重脓毒症中,如果血清中的维生素 D 水平降低(< 30 ng/mL),可以采取一种务实的临床方法来补充维生素 D。脓毒症患者似乎可以通过肠管服用一次超大剂量的维生素 D 3(胆钙化醇),然后每天或每月服用一次。肠外给药可保留给胃肠道、肝脏或肾脏功能障碍的败血症患者。未来需要进行专门针对脓毒症患者的临床试验,以评估维生素 D 的潜在优势。应阐明维生素 D 受体选择性激活剂(如帕立骨化醇)对脓毒症可能产生的影响。这强调了对维生素 D 在脓毒症中的潜在有益作用进行更多研究和确认的必要性。
{"title":"Should I Supplement Vitamin D in a Patient With Sepsis?","authors":"Vedran Kovacic","doi":"10.6705/j.jacme.202403_14(1).0001","DOIUrl":"10.6705/j.jacme.202403_14(1).0001","url":null,"abstract":"<p><p>Sepsis is a potentially fatal organ failure produced by the host's immune response to infection. It is critical to identify risk factors associated with a poor prognosis in septic patients in order to develop new therapy options. Vitamin D deficiency (25-hydroxyvitamin cholecalciferol < 20 ng/mL) is common in critical and septic patients. Serum vitamin D concentrations are associated with an increased incidence of mortality in critically ill adult patients. In critically ill patients, vitamin D supplementation (a very high vitamin D <sub>3</sub> or cholecalciferol loading dosage as a single bolus dose ranging from 400,000 to 540,000 IU) is feasible and safe. Some of the trials and their post-hoc analyses evaluating vitamin D supplementation in severely sick individuals, including septic patients, suggested possible benefits in mortality (reduced 28-day mortality in the range of 8.1%-17.5%), and other outcomes (reduction in hospital length in the range from 9 to 18 days, and decrease in duration of mechanical ventilation in the range from 5 to 10 days). Despite the fact that many studies support the provision of vitamin D to septic patients, there are still many studies that contradict this opinion, and there is still debate about the recommendation to use vitamin D in sepsis. A pragmatic clinical approach in severe sepsis could be supplementation of vitamin D if serum levels are diminished (< 30 ng/mL). It appears that a single ultrahigh dose of vitamin D <sub>3</sub> (cholecalciferol) could be administered to the septic patient via an enteral tube, followed by daily or monthly maintenance doses. Parenteral administration might be reserved for a subgroup of septic patients with gastrointestinal, hepatic, or renal dysfunction. Future clinical trials designed exclusively for septic patients are required to assess the potential advantages of vitamin D. Possible impacts of selective activators of vitamin D receptors, such as paricalcitol, should be elucidated in sepsis. This emphasizes the requirement for more study and confirmation of any potential beneficial effects of vitamin D in sepsis.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.6705/j.jacme.202403_14(1).0002
Bing-Hung Shih, Chien-Chun Yeh
The rapid progression of artificial intelligence (AI) in healthcare has greatly influenced emergency medicine, particularly in Taiwan-a nation celebrated for its technological innovation and advanced public healthcare. This narrative review examines the current status of AI applications in Taiwan's emergency medicine and highlights notable achievements and potential areas for growth. AI has wide capabilities encompass a broad range, including disease prediction, diagnostic imaging interpretation, and workflow enhancement. While the integration of AI presents promising advancements, it is not devoid of challenges. Concerns about the interpretability of AI models, the importance of dataset accuracy, the necessity for external validation, and ethical quandaries emphasize the need for a balanced approach. Regulatory oversight also plays a crucial role in ensuring the safe and effective deployment of AI tools in clinical settings. As its footprint continues to expand in medical education and other areas, addressing these challenges is imperative to harness the full potential of AI for transforming emergency medicine in Taiwan.
{"title":"Advancements in Artificial Intelligence in Emergency Medicine in Taiwan: A Narrative Review.","authors":"Bing-Hung Shih, Chien-Chun Yeh","doi":"10.6705/j.jacme.202403_14(1).0002","DOIUrl":"10.6705/j.jacme.202403_14(1).0002","url":null,"abstract":"<p><p>The rapid progression of artificial intelligence (AI) in healthcare has greatly influenced emergency medicine, particularly in Taiwan-a nation celebrated for its technological innovation and advanced public healthcare. This narrative review examines the current status of AI applications in Taiwan's emergency medicine and highlights notable achievements and potential areas for growth. AI has wide capabilities encompass a broad range, including disease prediction, diagnostic imaging interpretation, and workflow enhancement. While the integration of AI presents promising advancements, it is not devoid of challenges. Concerns about the interpretability of AI models, the importance of dataset accuracy, the necessity for external validation, and ethical quandaries emphasize the need for a balanced approach. Regulatory oversight also plays a crucial role in ensuring the safe and effective deployment of AI tools in clinical settings. As its footprint continues to expand in medical education and other areas, addressing these challenges is imperative to harness the full potential of AI for transforming emergency medicine in Taiwan.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"9-19"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01DOI: 10.6705/j.jacme.202312_13(4).0004
Kun-Yu Yang, Chen-Ching Chen
For several decades, hydrogen sulfide (H2S) has been a toxic gas affecting people, particularly in workplaces. However, no effective therapy is available to counteract H2S poisoning. Herein, we report the case of a 34-year-old male field worker who experienced H2S poisoning due to an accident at work. He presented to the emergency room with dyspnea, drowsiness, and dizziness. Computed tomography revealed a normal brain mass. An initial electrocardiogram revealed sinus tachycardia. Therefore, 10 mL nitrite was administered intravenously. However, the symptoms were not relieved as expected. Hyperbaric oxygen was promptly administered. Symptoms were relieved rapidly after three sessions of hyperbaric oxygen therapy. Subsequently, the patient completely recovered. During severe H2S intoxication, early administration of hyperbaric oxygen therapy can prevent the disruption of aerobic cellular respiration and save lives.
{"title":"Hyperbaric Oxygen Therapy in Hydrogen Sulfide Poisoning: A Case Report.","authors":"Kun-Yu Yang, Chen-Ching Chen","doi":"10.6705/j.jacme.202312_13(4).0004","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0004","url":null,"abstract":"<p><p>For several decades, hydrogen sulfide (H<sub>2</sub>S) has been a toxic gas affecting people, particularly in workplaces. However, no effective therapy is available to counteract H<sub>2</sub>S poisoning. Herein, we report the case of a 34-year-old male field worker who experienced H<sub>2</sub>S poisoning due to an accident at work. He presented to the emergency room with dyspnea, drowsiness, and dizziness. Computed tomography revealed a normal brain mass. An initial electrocardiogram revealed sinus tachycardia. Therefore, 10 mL nitrite was administered intravenously. However, the symptoms were not relieved as expected. Hyperbaric oxygen was promptly administered. Symptoms were relieved rapidly after three sessions of hyperbaric oxygen therapy. Subsequently, the patient completely recovered. During severe H<sub>2</sub>S intoxication, early administration of hyperbaric oxygen therapy can prevent the disruption of aerobic cellular respiration and save lives.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"159-161"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}